CASP3 and cancer: HSPB1 can interfere with cancer therapy by inhibiting cancer cellapoptosis.48 In addition, phosphorylatedHSPB1 suppresses actin polymerization, preventing cytoskeletal disruptionand caspase-3 activation.48 In our study,HSPB1 was upregulated 24 h after mEHT.